Optimising medicines use in older adults with intellectual disability who have epilepsy: challenges and perspectives
| dc.contributor.author | O'Dwyer, Máire | |
| dc.contributor.author | Watkins, L | |
| dc.contributor.author | McCallion, P | |
| dc.contributor.author | McCarron, M | |
| dc.contributor.author | Henman, M | |
| dc.contributor.author | Shankar, Rohit | |
| dc.date.accessioned | 2021-08-04T16:58:19Z | |
| dc.date.available | 2021-08-04T16:58:19Z | |
| dc.date.issued | 2021-01 | |
| dc.identifier.issn | 2042-0986 | |
| dc.identifier.issn | 2042-0994 | |
| dc.identifier.other | ARTN 20420986211025157 | |
| dc.identifier.uri | http://hdl.handle.net/10026.1/17390 | |
| dc.format.extent | 204209862110251-204209862110251 | |
| dc.format.medium | Electronic-eCollection | |
| dc.language | en | |
| dc.language.iso | eng | |
| dc.publisher | SAGE Publications | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | epilepsy | |
| dc.subject | intellectual disability | |
| dc.subject | polypharmacy | |
| dc.subject | seizures | |
| dc.subject | anti-seizure drugs | |
| dc.title | Optimising medicines use in older adults with intellectual disability who have epilepsy: challenges and perspectives | |
| dc.type | journal-article | |
| dc.type | Editorial | |
| plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707069200001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
| plymouth.volume | 12 | |
| plymouth.publication-status | Published | |
| plymouth.journal | Therapeutic Advances in Drug Safety | |
| dc.identifier.doi | 10.1177/20420986211025157 | |
| plymouth.organisational-group | /Plymouth | |
| plymouth.organisational-group | /Plymouth/Faculty of Health | |
| plymouth.organisational-group | /Plymouth/Users by role | |
| dc.publisher.place | England | |
| dc.identifier.eissn | 2042-0994 | |
| dc.rights.embargoperiod | Not known | |
| rioxxterms.versionofrecord | 10.1177/20420986211025157 | |
| rioxxterms.licenseref.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| rioxxterms.type | Journal Article/Review |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International